Psychedelic Hype Cycle; Employer KAP Coverage; MDMA Cost-Evaluation Analysis; Onboarding Underrepresented Groups
www.thetripreport.com
This week we’re looking at a few developments that occupy what we might call the “infrastructure and operational” layer required for psychedelic-assisted therapies, including: Employee sponsored coverage of ketamine assisted therapy Cost Evaluation Analysis of MDMA for PTSD based on data from MAPS phase III
Psychedelic Hype Cycle; Employer KAP Coverage; MDMA Cost-Evaluation Analysis; Onboarding Underrepresented Groups
Psychedelic Hype Cycle; Employer KAP…
Psychedelic Hype Cycle; Employer KAP Coverage; MDMA Cost-Evaluation Analysis; Onboarding Underrepresented Groups
This week we’re looking at a few developments that occupy what we might call the “infrastructure and operational” layer required for psychedelic-assisted therapies, including: Employee sponsored coverage of ketamine assisted therapy Cost Evaluation Analysis of MDMA for PTSD based on data from MAPS phase III